Catalyst Wire Dossier Catalyst Wire Dossier

Darifenacin hydrobromide

Darifenacin hydrobromide · POLYGEN PHARMACEUTICALS INC.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Darifenacin hydrobromide, covering 2020-01-06 to 2020-01-06. Get the full timeline:

Most recent: FDA Approved: DARIFENACIN — Original Application (POLYGEN PHARMACEUTICALS INC.)

See pricing